1. Liposomal temozolomide drug delivery using convection enhanced delivery
   Mirjam M. Nordling-David et al, 2017, Journal of Controlled Release CrossRef
2. Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line
   TADASHI ASHIZAWA et al, 2014 CrossRef
3. DNA and Histone Methylation in Lung Cancer
   Sophia Mastoraki et al, 2017 CrossRef
4. In Vitro and In Vivo Preclinical Effects of Type I IFNs on Gliomas
   Vasiliki Galani et al, 2017, Journal of Interferon & Cytokine Research CrossRef
5. DNA repair mechanisms and their clinical impact in glioblastoma.
   Hélène Erasimus et al, 2016, Mutat Res Rev Mutat Res CrossRef
6. Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents.
   Monika Szeliga et al, 2012, J Neurochem CrossRef
7. Recent Advances in Glioblastoma Treatment
   Atsuo Yoshino, 2013, Journal of Nihon University Medical Association CrossRef
8. BMP pathway suppression is an early event in inflammation-driven colon neoplasmatogenesis of uPA-deficient mice
   George S. Karagiannis et al, 2016, Tumor Biol. CrossRef
9. Interferon-β inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10
   SHINGO TAKANO et al, 2014 CrossRef
10. Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression
    Hongxiang Liu et al, 2018, Cancer Med CrossRef
11. Epigenetic Alterations as Contributors to the Pathogenesis, Detection, Prognosis and Treatment of Human Pre-invasive Neoplasia
    Stefan David et al, 2011 CrossRef
12. Modulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma In Vitro and In Vivo
    Sonja Stojković Burić et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
13. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
    Yoshinari Ozawa et al, 2020, Biochem Biophys Res Commun CrossRef
14. Interferon-β sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagy
    Kotaro Makita et al, 2019, Int J Oncol CrossRef
15. Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide
    Susan F. Murphy et al, 2016, Cancer Res CrossRef
16. Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models
    Maria Ciccolella et al, 2021, Cells CrossRef
17. Molecular mechanisms in temozolomide-resistant glioblastoma
    Sang Y. Lee et al, 2021 CrossRef
18. DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer
    Pablo Letelier et al, 2012, Clin Epigenet CrossRef
19. MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines
    Alessio Malacrida et al, 2022, Biology CrossRef
20. Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme
    Janaki Ramaiah Mekala et al, 2023, Metab Brain Dis CrossRef
21. Combination Therapy of Temozolomide, Ribavirin and Interferon-Beta for Glioblastoma In Vivo
    Genki Yazawa et al, 2023, Journal of Nihon University Medical Association CrossRef